CDC Will Test Travelers From Rwanda for Ebola-Like Marburg Virus
By Robin Foster HealthDay Reporter
TUESDAY, Oct. 8, 2024 -- As health officials work furiously to stem the spread of Marburg virus in Rwanda, U.S. health officials announced Monday that all passengers flying from that country to the United States will soon be screened for the often deadly disease.
"Starting the week of October 14, CDC [U.S. Centers for Disease Control and Prevention] will begin public health entry screening of travelers entering the United States who have been in Rwanda in the past 21 days," the U.S. Department of Health and Human Services said in a statement. "This screening aims to reduce the risk of importation of Marburg cases into the United States and the spread within U.S. communities."
As of Monday, 56 cases of Marburg had been confirmed in Rwanda, with 36 people in isolation and treatment, and 12 deaths, according to that country's Ministry of Health. No cases of Marburg virus have been reported in the United States at this point.
Travelers coming from Rwanda will be routed to one of three airports: Chicago O’Hare, JFK in New York and Washington Dulles in Virginia, the CDC said in a statement Monday, NBC News reported.
According to the statement, passengers landing at one of those airports will need to meet with CDC staffers for temperature checks and assessments of any other symptoms, such as sore throat, vomiting or rashes that often appear on the torso.
People infected by the virus can start showing symptoms two to 21 days after their exposure, according to the CDC.
Marburg is a virus that causes hemorrhagic fevers and internal bleeding, much like Ebola. Like Ebola, it spreads through contact with bodily fluids, including blood and semen. There is no treatment or vaccine. The death rate can be as high as 88%, according to the World Health Organization.
While the risk to the American public remains low, the CDC first began alerting U.S. doctors about Marburg last year.
In addition to the airport screening measures, the CDC issued a level 3 travel health notice on Monday, warning people against unnecessary travel to Rwanda.
The advisory suggested that anyone who must travel to the outbreak area watch for symptoms for 21 days.
“If you develop fever, chills, headache, muscle aches, rash, chest pain, sore throat, nausea, vomiting, diarrhea, or unexplained bleeding or bruising,” the advisory said, “isolate immediately and seek medical care.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-09 00:00
Read more
- Scientists Successfully Reverse Liver Fibrosis in Mice
- Protega Pharmaceuticals Receives FDA Approval for RoxyBond (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain
- Being Born Preterm Tied to Lifelong Harms in Employment, Education
- Novartis Scemblix Granted FDA Accelerated Approval in Newly Diagnosed CML
- Work-Related Stress Linked to Lower Odds of Average, Optimal Heart Health
- Late-Life Menopause Linked to Higher Asthma Risk
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions